Biohaven BHVN
NYSE BHVN
$15.21 +0.10 (+0.66%)
At close: Nov 11, 2026 · 4:00 PM EST

Biohaven (BHVN) Return on Equity [ROE] (2022 - 2026)

Updated

Biohaven's Return on Equity [ROE] was -828.16% in Q2 2026, down 438.91 percentage points from -389.24% a year earlier and down 114.75 percentage points from the prior quarter.

Analysis

Biohaven (BHVN) Return on Equity [ROE] (2022 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Biohaven came in at -310.75%, down 111.92 percentage points from FY2024.

  • Return on Equity [ROE] shows a four-year change of +519.98 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Equity [ROE] was -198.83% in FY2024 (-114.39 pp), -84.44% in FY2023 (+114.45 pp), -198.89% in FY2022 (+631.84 pp) and -830.73% in FY2021.
  • Quarterly Return on Equity [ROE] has moved between -4232.48% (Q4 2025) and -100.24% (Q2 2023) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has declined for ten straight quarters, with an average year-over-year change of -811.51 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2023 (a gain of 1043.46 percentage points); the worst was Q4 2025 (a drop of 4003.55 percentage points).
  • Per Business Quant data, BHVN's Return on Equity [ROE] in the three quarters before Q2 2026 was -713.41% (Q1 2026), -4232.48% (Q4 2025) and -1328.67% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Biohaven 2.28 Bn 1.18 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -832.30%
Mar 31, 2026 -713.50%
Dec 31, 2025 -4,232.73%
Sep 30, 2025 -1,328.75%
Jun 30, 2025 -389.18%
Mar 31, 2025 -260.16%
Dec 31, 2024 -228.88%
Sep 30, 2024 -229.83%
Jun 30, 2024 -217.89%
Mar 31, 2024 -141.82%
Dec 31, 2023 -113.73%
Sep 30, 2023 -137.21%
Jun 30, 2023 -100.30%
Mar 31, 2023 -107.58%
Dec 31, 2022 -178.49%
Sep 30, 2022 -672.54%
Jun 30, 2022 -1,143.71%
API Access

Biohaven Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BHVN&period=max&api_key=YOUR_API_KEY